The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-Isopropyl-1H-indazole-3-carboxylic acid [1-(tetrahydro-pyran-4-ylmethyl)-piperidin-4-yl]-amide tartarate ID: ALA5286277
Max Phase: Preclinical
Molecular Formula: C26H38N4O8
Molecular Weight: 384.52
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)n1nc(C(=O)NC2CCN(CC3CCOCC3)CC2)c2ccccc21.O=C(O)C(O)C(O)C(=O)O
Standard InChI: InChI=1S/C22H32N4O2.C4H6O6/c1-16(2)26-20-6-4-3-5-19(20)21(24-26)22(27)23-18-7-11-25(12-8-18)15-17-9-13-28-14-10-17;5-1(3(7)8)2(6)4(9)10/h3-6,16-18H,7-15H2,1-2H3,(H,23,27);1-2,5-6H,(H,7,8)(H,9,10)
Standard InChI Key: GKVRUVOZMDJHIC-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 40 0 0 0 0 0 0 0 0999 V2000
-3.2963 -1.6775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2975 -2.5046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5829 -2.9173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8647 -2.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8695 -1.6738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5847 -1.2648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0852 -1.4139 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5955 -2.0794 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0774 -2.7507 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.8179 -3.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3663 -4.1497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0103 -3.7004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8349 -0.6280 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.0293 -0.4519 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2209 0.3338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0276 0.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2786 1.2899 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7260 1.9026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0808 1.7282 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3354 0.9408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9792 2.6876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7869 2.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3342 2.2395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1386 2.4076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3987 3.1914 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8477 3.8074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0369 3.6397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3903 -0.0184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1613 3.4354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5737 2.7209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1613 2.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5737 1.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3987 1.2921 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.1613 0.5777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3364 2.0065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.3987 2.7209 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3364 3.4354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.5737 4.1497 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
5 4 1 0
5 6 2 0
6 1 1 0
7 5 1 0
8 7 2 0
4 9 1 0
9 8 1 0
9 10 1 0
10 11 1 0
10 12 1 0
7 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
15 20 1 0
19 20 1 0
18 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
22 27 1 0
26 27 1 0
13 28 2 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 2 0
32 34 1 0
31 35 1 0
30 36 1 0
29 37 2 0
29 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 384.52Molecular Weight (Monoisotopic): 384.2525AlogP: 3.24#Rotatable Bonds: 5Polar Surface Area: 59.39Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.48CX LogP: 2.10CX LogD: 0.03Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.86Np Likeness Score: -1.48
References 1. Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Ravella SR, Bogaraju N, Middekadi VR, Subramanian R, Palacharla RC, Benade V, Muddana N, Abraham R, Medapati RB, Thentu JB, Mekala VR, Petlu S, Lingavarapu BB, Yarra S, Kagita N, Goyal VK, Pandey SK, Jasti V.. (2021) Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease., 64 (15.0): [PMID:34251799 ] [10.1021/acs.jmedchem.1c00703 ]